Seeing Is Believing

Currently out of the existing stock ratings of Robert Driscoll, 292 are a BUY (89.57%), 32 are a HOLD (9.82%), 2 are a SELL (0.61%).
Analyst Robert Driscoll, currently employed at WEDBUSH, carries an average stock price target met ratio of 46.99% that have a potential upside of 55.68% achieved within 266 days.
Robert Driscoll’s has documented 614 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on TYRA, Tyra Biosciences.
Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for REPL (REPLIMUNE GROUP) at 4/13/2026. The price target of $2 was fulfilled within 1 day with a profit of $2.76 (57.98%) receiving and performance score of 579.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2020
$5
$-0.15 (-2.91%)
$5
9 months 27 days ago
(14-Nov-2025)
9/14 (64.29%)
$0.48 (10.62%)
477
Buy Since 05-Nov-2021
$5
$-0.15 (-2.91%)
$5
1 years 5 months 10 days ago
(31-Mar-2025)
4/10 (40%)
$1.51 (43.27%)
420
Buy Since 17-Dec-2020
$5
$-0.15 (-2.91%)
$5
1 years 7 months 20 days ago
(21-Jan-2025)
5/18 (27.78%)
$1.79 (55.76%)
671
Buy Since 02-Feb-2022
$5
$0.71 (16.55%)
$4
4 years 7 months 9 days ago
(02-Feb-2022)
1/2 (50%)
$2.11 (73.01%)
980
Buy Since 05-Mar-2020
$7
5 years 2 months 14 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll most bullish on?
Which stock is Robert Driscoll most reserved on?
What Year was the first public recommendation made by Robert Driscoll?